Skip to main content

Advertisement

SpringerLink
Log in

Complete and durable remission in a patient with life-threatening scleromyxedema treated with high-dose melphalan and BU with auto-SCT

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Rongioletti F, Rebora A . Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol 2001; 44: 273–281.

    Article  CAS  PubMed  Google Scholar 

  2. Dinneen AM, Dicken CH . Scleromyxedema. J Am Acad Dermatol 1995; 33: 37–43.

    Article  CAS  PubMed  Google Scholar 

  3. Gabriel SE, Perry HO, Oleson GB, Bowles CA . Scleromyxedema: a scleroderma-like disorder with systemic manifestations. Medicine (Baltimore) 1988; 67: 58–65.

    Article  CAS  Google Scholar 

  4. Feasel AM, Donato ML, Duvic M . Complete remission of scleromyxedema following autologous stem cell transplantation. Arch Dermatol 2001; 137: 1071–1072.

    CAS  PubMed  Google Scholar 

  5. Lacy MQ, Hogan WJ, Gertz MA, Dispenzieri A, Rajkumar SV, Hayman S et al. Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation. Arch Dermatol 2005; 141: 1277–1282.

    Article  PubMed  Google Scholar 

  6. Donato ML, Feasel AM, Weber DM, Prieto VG, Giralt SA, Champlin RE et al. Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation. Blood 2006; 107: 463–466.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Illa I, de la TC, Rojas-Garcia R, Altes A, Blesa R, Sierra J et al. Steady remission of scleromyxedema 3 years after autologous stem cell transplantation: an in vivo and in vitro study. Blood 2006; 108: 773–774.

    Article  CAS  PubMed  Google Scholar 

  8. Iranzo P, Lopez-Lerma I, Blade J, Rovira M, Herrero C . Scleromyxoedema treated with autologous stem cell transplantation. J Eur Acad Dermatol Venereol 2007; 21: 129–130.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Medical Oncology, Department of Medicine, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada

    T Cheng & D A Stewart

  2. Medical School, University of Calgary, Calgary, Alberta, Canada

    V Gnanakumar

  3. Department of Pathology, Chinook Regional Hospital Laboratory, Chinook Health, Lethbridge, Alberta, Canada. E-mail: tinachen@cancerboard.ab.ca,

    C Hegedus

Authors
  1. T Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V Gnanakumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C Hegedus
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D A Stewart
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cheng, T., Gnanakumar, V., Hegedus, C. et al. Complete and durable remission in a patient with life-threatening scleromyxedema treated with high-dose melphalan and BU with auto-SCT. Bone Marrow Transplant 42, 215–217 (2008). https://doi.org/10.1038/bmt.2008.148

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.148

  • Springer Nature Limited

This article is cited by

  • Skleromyxödem

    • A. Kreuter
    • M. Stücker
    • K. Möllenhoff

    Zeitschrift für Rheumatologie (2012)

Search

Navigation